Hodgkins Lymphoma

URCC 19185

Multicenter Randomized Controlled Trial comparing Brief Behavioral Therapy for Cancer Related Insomnia (BBT-CI) and Healthy Eating Education Learning (HEAL)

EAY191-A3 Cohort 3 (Pancreatic Cancer) Temp. Suspended as of 4/15/24

Palbociclib and Binimetinib in RAS-Mutant Cancers: A ComboMATCH Treatment Trial

EAQ211

Social Genomic Mechanisms of Health Disparities among Adolescent and Young Adult (AYA) Survivors of Hodgkin and Non-Hodgkin Lymphoma

EAY191-E4 Accrual to EAY191-E4 is Temporarily Suspended effective January 12, 2024

ComboMATCH Treatment Trial E4: Nilotinib and Paclitaxel in Patients with Prior Taxane-Treated Solid Tumors

EAY191 (ComboMATCH) If biopsy needed, TBD at MBMC

Molecular Analysis for Combination Therapy Choice

ALLIANCE A212102 AT MBMC ONLY As of 8/1/23 the following Healthy Control Cohorts are Open (all others are Closed as of 2/22/23): Non-White Male Participants Age 60 or More Without Cancer Diagnosis and Non-White Male Participants Under Age 60 Without Cancer Diagnosis Effective with the release of Update #02, enrollment to the thyroid, melanoma, and sarcoma cancer cohorts has been closed.

Blinded Reference Set For Multicancer Early Detection Blood Tests

URCC 19075 MBMC ONLY

Multi-Center Randomized Controlled Phase II Trial of Exercise to Treat Chemotherapy-Induced Peripheral Neuropathy (CIPN)

Disparities in REsults of Immune Checkpoint Inhibitor Treatment (DiRECT): A Prospective Cohort Study of Cancer Survivors Treated with anti-PD-1/anti-PD-L1 Immunotherapy in a Community Oncology Setting

URCC 18007

Randomized Placebo Controlled Trial of Bupropion For Cancer Related Fatigue

Clinical Trials

Quick Links